Gerl A - Search Results

1

Late relapse of germ cell tumors after cisplatin-based chemotherapy.

Gerl A, Clemm C, Schmeller N, Hentrich M, Lamerz R, Wilmanns W. Gerl A, et al. Ann Oncol. 1997 Jan;8(1):41-7. doi: 10.1023/a:1008253323854. Ann Oncol. 1997. PMID: 9093706 Free article. Review.

2

[Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy].

Gerl A, Clemm C, Kohl P, Niedermaier J, Schalhorn A. Gerl A, et al. Med Klin (Munich). 1994 May 15;89(5):240-4. Med Klin (Munich). 1994. PMID: 7519720 German.

3

Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.

Gerl A, Clemm C, Schmeller N, Dienemann H, Weiss M, Kriegmair M, Löhrs U, Wilmanns W. Gerl A, et al. Br J Cancer. 1994 Nov;70(5):960-5. doi: 10.1038/bjc.1994.429. Br J Cancer. 1994. PMID: 7524606 Free PMC article. Clinical Trial.

4

Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumours.

Gerl A, Clemm C, Schmeller N, Dienemann H, Lamerz R, Kriegmair M, Wilmanns W. Gerl A, et al. Ann Oncol. 1995 May;6(5):483-8. doi: 10.1093/oxfordjournals.annonc.a059219. Ann Oncol. 1995. PMID: 7545430 Free article. Clinical Trial.

5

Prognosis after salvage treatment for unselected male patients with germ cell tumours.

Gerl A, Clemm C, Schmeller N, Hartenstein R, Lamerz R, Wilmanns W. Gerl A, et al. Br J Cancer. 1995 Oct;72(4):1026-32. doi: 10.1038/bjc.1995.456. Br J Cancer. 1995. PMID: 7547217 Free PMC article.

6

Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.

Gerl A, Clemm C, Lamerz R, Mann K, Wilmanns W. Gerl A, et al. Eur J Cancer. 1993;29A(7):961-5. doi: 10.1016/s0959-8049(05)80202-3. Eur J Cancer. 1993. PMID: 7684597

7

Etoposide, cisplatin, bleomycin, and cyclophosphamide (ECBC) as first-line chemotherapy for poor-risk non-seminomatous germ cell tumors.

Gerl A, Clemm C, Hentrich M, Hartenstein R, Wilmanns W. Gerl A, et al. Acta Oncol. 1993;32(5):541-6. doi: 10.3109/02841869309096115. Acta Oncol. 1993. PMID: 7692901

8

Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancer.

Gerl A, Clemm C, Kohl P, Schalhorn A, Wilmanns W. Gerl A, et al. Clin Exp Metastasis. 1994 May;12(3):226-30. doi: 10.1007/BF01753890. Clin Exp Metastasis. 1994. PMID: 8194197

9

Testicular tumor after cisplatin-based chemotherapy for germ cell malignancy.

Gerl A, Clemm C, Kohl P, Wilmanns W. Gerl A, et al. Eur Urol. 1994;25(3):216-9. doi: 10.1159/000475286. Eur Urol. 1994. PMID: 8200404

10

Cisplatin-based chemotherapy of primary extragonadal germ cell tumors. A single institution experience.

Gerl A, Clemm C, Lamerz R, Wilmanns W. Gerl A, et al. Cancer. 1996 Feb 1;77(3):526-32. doi: 10.1002/(SICI)1097-0142(19960201)77:3<526::AID-CNCR15>3.0.CO;2-6. Cancer. 1996. PMID: 8630961 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters